Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening

Lianhuaqingwen (LHQW) capsule, a herb medicine product, has been clinically proved to be effective in coronavirus disease 2019 (COVID-19) pneumonia treatment. However, human exposure to LHQW components and their pharmacological effects remain largely unknown. Hence, this study aimed to determine hum...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Acta Pharm Sin B
المؤلفون الرئيسيون: Chen, Xiaofei, Wu, Yunlong, Chen, Chun, Gu, Yanqiu, Zhu, Chunyan, Wang, Suping, Chen, Jiayun, Zhang, Lei, Lv, Lei, Zhang, Guoqing, Yuan, Yongfang, Chai, Yifeng, Zhu, Mingshe, Wu, Caisheng
التنسيق: Artigo
اللغة:Inglês
منشور في: Elsevier 2021
الموضوعات:
Original Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC7547831/
https://ncbi.nlm.nih.gov/pubmed/33072499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2020.10.002
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة